Literature DB >> 12909315

Andersen mutations of KCNJ2 suppress the native inward rectifier current IK1 in a dominant-negative fashion.

Philipp S Lange1, Fikret Er, Natig Gassanov, Uta C Hoppe.   

Abstract

OBJECTIVE: The Andersen's syndrome is a hereditary disease, which is characterized by cardiac arrhythmias, periodic paralysis and dysmorphic features. Recently, mutations of the KCNJ2 gene, which encodes the inward rectifying potassium channel subunit Kir2.1, have been identified in affected individuals. However, the functional effects of these mutations have not yet been fully elucidated. METHODS AND
RESULTS: To clarify this situation we generated known Andersen disease mutants of KCNJ2 which did not yield any measurable K(+) currents in CHO cells indicating that the Andersen mutants failed to form functional homomultimeric complexes. EGFP-tagged KCNJ2 wild-type and mutant channels distributed in a similar homogeneous pattern in the cell membrane suggesting that protein trafficking was not altered by the Andersen mutations but rather implicating that the mutations rendered the KCNJ2 channel non-functional. In heterologous coexpression experiments the Andersen mutants exerted a dominant-negative effect on wild-type KCNJ2. However, the extent of suppression varied between the different KCNJ2 mutants. Given our results in CHO cells, we expressed the disease mutant KCNJ2-S136F in neonate rat cardiomyocytes using adenoviral gene transfer to test the effect of Andersen mutants on native I(K1). I(K1) density was indeed significantly reduced in KCNJ2-S136F-infected cells (n=9) compared to control cells (n=9) over a voltage range from -70 to -150 mV (P<0.05).
CONCLUSION: These results support that Kir2.x channels are a critical component of native I(K1) in neonate rat cardiomyocytes and that a dominant-negative suppression of I(K1) in native cells is the pathophysiological correlate of the Andersen's syndrome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12909315     DOI: 10.1016/s0008-6363(03)00434-6

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  14 in total

Review 1.  Cardiac ion channels.

Authors:  Birgit T Priest; Jeff S McDermott
Journal:  Channels (Austin)       Date:  2015-08-20       Impact factor: 2.581

2.  Inhibition of cardiomyocyte automaticity by electrotonic application of inward rectifier current from Kir2.1 expressing cells.

Authors:  Teun P de Boer; Toon A B van Veen; Marien J C Houtman; John A Jansen; Shirley C M van Amersfoorth; Pieter A Doevendans; Marc A Vos; Marcel A G van der Heyden
Journal:  Med Biol Eng Comput       Date:  2006-04-20       Impact factor: 2.602

3.  Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes.

Authors:  Dennis Rottlaender; Kerstin Boengler; Martin Wolny; Guido Michels; Jeannette Endres-Becker; Lukas J Motloch; Astrid Schwaiger; Astrid Buechert; Rainer Schulz; Gerd Heusch; Uta C Hoppe
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

4.  In vivo and in vitro functional characterization of Andersen's syndrome mutations.

Authors:  Saïd Bendahhou; Emmanuel Fournier; Damien Sternberg; Guillaume Bassez; Alain Furby; Carole Sereni; Matthew R Donaldson; Marie-Madeleine Larroque; Bertrand Fontaine; Jacques Barhanin
Journal:  J Physiol       Date:  2005-04-14       Impact factor: 5.182

5.  Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7).

Authors:  Masato Tsuboi; Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2006-03       Impact factor: 6.343

6.  Cholesterol sensitivity and lipid raft targeting of Kir2.1 channels.

Authors:  Victor G Romanenko; Yun Fang; Fitzroy Byfield; Alexander J Travis; Carol A Vandenberg; George H Rothblat; Irena Levitan
Journal:  Biophys J       Date:  2004-10-01       Impact factor: 4.033

7.  Andersen-Tawil syndrome.

Authors:  Andrew H Smith; Frank A Fish; Prince J Kannankeril
Journal:  Indian Pacing Electrophysiol J       Date:  2006-01-01

8.  UCP2 Modulates Cardioprotective Effects of Ru360 in Isolated Cardiomyocytes during Ischemia.

Authors:  Lukas J Motloch; Sara Reda; Martin Wolny; Uta C Hoppe
Journal:  Pharmaceuticals (Basel)       Date:  2015-08-04

9.  UCP3 Regulates Single-Channel Activity of the Cardiac mCa1.

Authors:  Lukas J Motloch; Tina Gebing; Sara Reda; Astrid Schwaiger; Martin Wolny; Uta C Hoppe
Journal:  J Membr Biol       Date:  2016-07-01       Impact factor: 1.843

10.  By Regulating Mitochondrial Ca2+-Uptake UCP2 Modulates Intracellular Ca2+.

Authors:  Lukas Jaroslaw Motloch; Robert Larbig; Tina Gebing; Sara Reda; Astrid Schwaiger; Johannes Leitner; Martin Wolny; Lars Eckardt; Uta C Hoppe
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.